Buffered Anesthetic Solution in the Treatment of Mandibular Primary Molars

Damascus University

Status and phase: Completed; Phase 4

Conditions: Local Anesthesia

Treatments: Combination Product: Buffered lidocaine in inferior alveolar nerve block injection; Drug: lidocaine 2% in inferior alveolar nerve block injection

Study type: Interventional

Funder types: Other

Identifiers

NCT05793905

UDDS-Pedo-03-2023

Details and patient eligibility

About

In a prospective, randomized clinical trial, triple-blind, split-mouth study, 40 children aged between 7 to 10 with bilateral mandibular primary molars were diagnosed with pulpitis. The test agent was 2% lidocaine with 1:80.000 epinephrine buffered with sodium bicarbonate 8.4% at a ratio of 1/10, as opposed to the control agent, which was non- buffered 2% lidocaine with 1:80,000 epinephrine. The pain will be assessed during inferior alveolar nerve block injection (IANB) and the effectiveness of anesthesia using the subjective Wong-Baker visual analog scale, the objective sound, eye, and motor (SEM) scale, and the physiological pain scale (pulse rate) using a pulse oximeter. The investigator has confirmed the onset of anesthesia after lip tongue-numbing by probing the gingiva until there is no pain. Endo-ice has been used to assess the onset of pulp anesthesia.

Full description

In a prospective, randomized clinical trial and triple-blind, split mouth study, 40 children aged between 7 to 10 with bilateral mandibular primary molars were diagnosed with pulpitis. Random numbers between 1 to 40 were assigned to patients, with some receiving buffered lidocaine at their initial appointment while others received unbuffered lidocaine. The solutions have been switched up for the second session, which has been set for one week later. The test agent was 2% lidocaine with 1:80.000 epinephrine buffered with sodium bicarbonate 8.4% at a ratio of 1/10, as opposed to the control agent, non-buffering 2% lidocaine with 1:80,000 epinephrine. Buffered lidocaine has been freshly prepared by mixing sodium bicarbonate (8.4%) with the anaesthetic solution (lidocaine 2% with epinephrine 1/80.000) in a 1:10 ratio by volume. Two percent benzocaine gel is applied at the injection site for one minute before inferior alveolar nerve block injection (IANB). The investigator has assessed pain during IANB injection using the subjective Wong-Baker visual analogue scale, the objective sound, eye, and motor (SEM) scale, and the physiological pain scale (pulse rate) using a pulse oximeter. After administering the IANB injection, the investigator has confirmed the onset of anaesthesia after lip and tongue numbing by probing the gingiva every 30 seconds until there is no pain. Endo-ice has been used to assess the onset of pulp anaesthesia every 30 seconds. The effectiveness of anaesthesia has been assessed during the preparation of the pulp chamber using subjective, objective, and physiological pain scales. Finally, the numerical data will be statistically analysed, and any statistically significant values will be investigated.

Enrollment: 40 patients

Sex: All

Ages: 6 to 10 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Children who are healthy and free of any underlying conditions that might make local anesthesia impossible to administer.
• Children that are not allergic to (lidocaine, adrenaline, or sodium bicarbonate).
• Children aged 6-10 years old
• Cooperative children on Frankel scale (positive or absolute positive).
• children needing bilateral (right and left) endodontic treatment for the mandibular primary molars.
• A positive outcome on the cold test for the target tooth.

Exclusion criteria

• Uncooperative children on Frankel's scale (passive or absolute positive).
• The presence of a fistula.
• The presence of an abscess associated with the target tooth.
• The presence of a periapical lesion radially.
• Negative response to the cold test.
• Children suffering from systemic conditions.
• Children who are allergic to (lidocaine, adrenaline, sodium bicarbonate).

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Triple Blind

---

40 participants in 2 patient groups

Buffered lidocaine

Experimental group

Description:

Inferior alveolar nerve block with buffered anesthetic solution (2% lidocaine with 1/80000 adrenaline mixed with sodium bicarbonate 8.4%)

Treatment:

Combination Product: Buffered lidocaine in inferior alveolar nerve block injection

Lidocaine 2%

Other group

Description:

Control group: Inferior alveolar nerve block with anesthetic solution (Lidocaine 2% with adrenaline 1.80000).

Treatment:

Drug: lidocaine 2% in inferior alveolar nerve block injection